Revive Therapeutics Ltd (RVVTF)

[RioDad]

John,

I think many shorts were expecting next PR to contain hard data. I’ve been trying to set expectations that December is more realistic for first indication of results...

Why December?
FDA likes 2 months of safety data to align with data releases.
October & November would provide that.

Revive seems to be adhering to pre-Covid testing standards that are observed by theFDA. It’s a good standard to practice, but I doubt “shorts“ like that. If Bucillamine is tested in an unimpeachable fashion, then there are no set backs at the time of approval. In turn, public confidence should be high no matter the political conditions or forecasts.

It is curious that this is by far the biggest trading day in weeks.
That could be a sell off by Revive for a payment or agreement of some sort around $150k to $300k